Newsbenzinga
Coinbase CEO-Backed NewLimit Claims Aging Reversal Breakthrough, Raises $435 Million For Human Trials
· Published
Article summary
Brian Armstrong-backed NewLimit says it reversed aging in human cells and will begin first clinical trials next year after raising $435M.
An excerpt from the original article.
Comments —
Loading comments…